ABSOLV3
Live / Applied — Statement of use — non-final action mailed (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 01 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98529028
- Mark type
- Stylized text
- Filed
- 01 May 2024
- Published for opposition
- 10 Dec 2024
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic products, namely, amniotic patches applied to the skin that are derived from human amnion for implantation and for topical treatment all to promote healing and rejuvenation of wounded bodily tissue; Therapeutic products, namely, amniotic patches applied to internal organs and bodily tissues that are derived from human amnion for implantation and for topical treatment all to promote healing and rejuvenation of wounded bodily tissue
Owner
- Amnio Technology, LLC, Phoenix, AZ, US
- Amnio Technology, LLC, Phoenix, AZ, US
Prosecution history
- 26 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Feb 2026 — NON-FINAL ACTION E-MAILED
- 26 Feb 2026 — SU - NON-FINAL ACTION - WRITTEN
- 01 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Jul 2025 — USE AMENDMENT FILED
- 01 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 04 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION
- 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Nov 2024 — ASSIGNED TO EXAMINER
- 27 Oct 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 May 2024 — NEW APPLICATION ENTERED